Among the 44.9% of VUS that were reclassified, most were upgraded to pathogenic or likely pathogenic. A significant percentage of variants of uncertain significance (VUS) in GLA, the gene underlying ...
SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in ...
Xiaolan Fang, Henry Ford Health and Michigan State University: Optical Genome Mapping for Hematologic Malignancy-Henry Ford Health System Experience (P675) Atlas Mashayekhi Sardoo, Greenwood Genetic ...
GeneDx showcases leadership in exome and genome quality, expanded access through non-genetics ordering, and AI-driven innovations that enhance speed, scale, and diagnostic impact GAITHERSBURG, ...
GeneDx showcases leadership in exome and genome quality, expanded access through non-genetics ordering, and AI-driven innovations that enhance speed, scale, and diagnostic impact GeneDx (Nasdaq: WGS), ...
A systematic review of 52 scientific papers submitted to a world-leading clinical genetics journal from multiple scientists over a two-year period reveals that not a single one named critical gene ...
If you regularly deliver the same presentation, you may need to make small adjustments for different audiences or time constraints–for example, by omitting some slides. In PowerPoint, you can save ...
Supported by the Dr Ellen Li Charitable Foundation (A.K.), the Kerry Kuok Foundation (A.K.), the Health and Medical Research Fund (03143406) (A.K.), the Asian Fund for Cancer Research (A.K.), and the ...
Genetic risk models, including PREMMplus and BOADICEA/CanRisk, refine breast cancer risk assessment by incorporating genetic status and polygenic risk scores. Challenges in classifying gene variants, ...
The ACMG SF v3.3 list serves as our 84 genes of interest (ACMG 84), with 41 in the CV subset. GnomAD v4.1.0 is our genomic database. We defined an uncertainty coefficient (UC) to evaluate diagnostic ...
Misdiagnosis or underdiagnosis of rare diseases in patients with diagnoses of common diseases can lead to delayed or inappropriate treatments, thereby complicating the management of both rare and ...
The American College of Medical Genetics and Genomics (ACMG) has released its highly anticipated 2025 update to the recommended minimum gene list for the reporting of secondary findings (SF) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results